Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE, YTTRIUM-SUP(90)Y CHELATE

Metastatic Pancreatic Cancer

Gilead Sciencesantibody_drug_conjugatePhase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

330 Active assets in the Metastatic Pancreatic Cancer cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Chinese PLA General Hospital
Phase 4BBB
Metformin
State University of New York - Downstate Medical Center
Phase 2BBB
FLUOROURACILUM
Jonsson Comprehensive Cancer Center
Phase 4BBB
S-1
Liu Xiufeng
Phase 4BB
Eloxatin
Jonsson Comprehensive Cancer Center
Phase 4BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE, YTTRIUM-SUP(90)Y CHELATE is also rated in:

pancreatic neoplasmDormant
CCC
Indicative ·
52 / 100
View asset →
pancreatic adenocarcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →